|
|
||||||||
Ann Thorac Surg 2004;77:672-675
© 2004 The Society of Thoracic Surgeons
a Division of Cardiac Surgery, Tor Vergata University, Rome, Italy
Accepted for publication August 6, 2003.
* Address reprint requests to Dr Zeitani, Division of Cardiac Surgery, Tor Vergata University, European Hospital, Via Portuense 700, 00149 Rome, Italy.
e-mail: zeitani{at}hotmail.com
| Abstract |
|---|
|
|
|---|
METHODS: From October 1999 to December 2002, 2400 consecutive patients underwent median sternotomy: 207 patients had sternal wound complications: 3 patients (0.125%) had mediastinitis, 66 patients (2.75%) had aseptic deep sternal wound dehiscence, and 138 patients (5.75%) had superficial wound dehiscence. The latter are the object of the present study; patients entered a protocol of skin wound care on an outpatient basis. The first 96 consecutive patients (group 1) required medications three times a week until complete healing. The last 42 patients (group 2) were treated by extensive surgical debridement of skin and subcutaneous tissue, direct closure of the superficial layers, and suture removal after 15 days.
RESULTS: The two groups were comparable as to age, sex, and preoperative risk factors. The incidence of contaminated wounds was similar in the two groups (32 of 96 in group 1 and 11 of 42 in group 2; p = NS). The length of treatment was 29.7 days (range 2 to 144 days) for group 1 and 12.2 days (range 2 to 37 days) for group 2 (p < 0.0001). The mean number of medical treatments was 9.4 per patient in group 1 and 3.7 per patient in group 2 (p < 0.0001).
CONCLUSIONS: Surgical debridement and primary closure of superficial surgical wound dehiscence after median sternotomy is a safe and valid treatment. Wound infection is not a contraindication to surgical treatment. Primary closure may contribute to reduce the risk for later infection. It also definitely contributes to decreasing healing time and strongly lessens patients' discomfort, diminishing hospital costs and hospital staff workload.
| Introduction |
|---|
|
|
|---|
Superficial wound dehiscence can be managed by topical treatment, with delayed secondary healing, using irrigation of disinfectant agents and gauze packing. Alternatively, surgical treatment consists of extensive debridement and primary skin closure.
Prolonged treatment, patients' discomfort, and medical staff involvement required for secondary wound healing encouraged us to try surgical treatment and primary closure. We report the outcome of 96 patients who underwent conventional treatment compared with a second group of 42 patients who underwent surgical debridement and direct closure.
| Material and methods |
|---|
|
|
|---|
The first consecutive 96 patients (group 1) were treated by local debridement of fibrin deposition and medication with solution of chloramine (Dakin) steeped gauzes. Medications were then repeated in the outpatient clinic three times a week, until complete healing. The last 42 patients (group 2) were treated by extensive surgical debridement of skin and subcutaneous tissue and direct closure of the superficial layers. Depending on severity of wound dehiscence they were treated in the outpatient clinic, using local anesthesia, or temporarily readmitted to the surgical ward, operated on under general anesthesia, and discharged home after 24 hours. In these patients surgical debridement included necrotic and devascularised tissue. In some patients, when wound dehiscence was particularly large and tension on suture lines was expected, the subcutaneous layer was widely mobilized. However, it was not necessary to mobilize the pectoralis major muscles in any patient. Use of the electrocauthery was avoided to prevent tissue damage. The subcutaneous and skin layers were first reapproximated by large #2 silk interrupted sutures, placed at a 2-cm distance from each other, and made tight. Approximation of the skin edges was then improved by placement of several loose #2-0 silk interrupted sutures. No absorbable suture lines for the subcutaneous layer were used. Culture samples were taken before the treatment. A single intravenous injection of 2-g ceftizoxime was given before the procedure to patients with aseptic wounds; an antibiogram-guided antibiotic therapy was given to patients with positive cultures.
The two groups were compared with regard to known preoperative risk factors for surgical wound dehiscence and infection by means of
2 table or two-tail t test for unpaired data, for dichotomic or continues variables, respectively. The number of required medications and length of treatment were compared with two-tail t test for unpaired data. A p value less than 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
The length of treatment was 29.7 days (range 2 to 144 days) for group 1 and 12.2 days (range 2 to 37 days), including the day of surgical direct closure and sutures removal, for group 2 (p < 0.0001). The mean number of medical treatments was 9.4 per patient in group 1 and 3.7 per patient in group 2 (p < 0.0001).
| Comment |
|---|
|
|
|---|
Recently, a vacuum-assisted closure (VAC) system has been introduced in cardiac surgery as a method to treat wound dehiscence. Tang and associates [20] reported the use of VAC (KCI, Oxfordshire, UK) for deep and superficial wound dehiscence. They reported a mean duration of treatment of 27 days (range 8 to 66 days), changing wound dressing every 48 hours. Although all patients experienced complete healing, this procedure appears costly and time consuming. In fact, considering the healing time and the number of medications per patient, it seems comparable with the topical treatment and secondary wound healing approach.
The following factors encouraged us to try primary SWD closure regardless of the presence of positive cultures: less patient discomfort and less medical staff involvement due to the shorter length of treatment.
Our data indicate that superficial wound dehiscence, with or without superimposed infection, was treated effectively both by a conservative approach and a more aggressive surgical strategy. However there was a striking difference in the length of treatment, such as the number of required medications, between the two methods, with the surgical method clearly proving most effective.
It has to be pointed out that we did not use a separate suture line to close the subcutaneous layer. Patients with wound dehiscence returned to our unit after a mean period of 29.3 days (range 4 to 115 days) after operation. At that time, due to inflammatory process, the subcutaneous tissue would lose its elasticity and the suture line under tension will cut through. Therefore we included both the subcutaneous and skin layers in the interrupted unabsorbable suture line. Most patients in group 2, regardless of culture results, underwent surgical revision of the wound dehiscence within 2 to 3 days from presentation at the outpatient clinic.
Faster healing means reduced hospital cost and reduced need of nurses and physicians for a prolonged ambulatory care, because most patients requiring repeated medications would return to the hospital for treatment. In all patients in group 1 repeated medications were performed on an outpatient basis, with a mean of 29.7 visits (range 2 to 144 visits) per patient, lasting for a mean of 4 weeks (range 1 to 48 weeks). Direct closure would have greatly reduced discomfort and loss of time in most of these patients; moreover, ambulatory care often requires involvement of other members of the patient's family.
Faster healing might also prevent migration of a superimposed infection to the mediastinum, which has been described as a life-threatening complication in conservative treatment of superficial wound dehiscence [21], especially in patients with concomitant risk factors, such as diabetes mellitus, poor nutritional status, or advanced age.
The presence of a superficial superimposed infection does not seem to contraindicate direct closure in our experience, as suggested by the prompt healing observed in most patients with positive cultures. Nevertheless, failure of primary closure was observed in 2 of 11 patients (18%) with positive cultures, which required topical treatment and subsequently underwent an uneventful secondary healing. Both patients had positive cultures for Staphylococcus aureus; 1 patient required revision of the lower two-thirds of the sternal wound and presented only minor bacterial contamination (10,000 colonies); the other patient required revision of the lower third of the wound and bacterial contamination was high (> 105 colonies). The other 7 patients who presented positive cultures for Staphylococcus aureus experienced complete healing. The extension of wound dehiscence and the amount of bacterial colonies was high in most patients: 3 patients required revision of the all length of the sternal wound and presented extensive to confluent bacteria colonies (1 patient had < 105 colonies, and the other 2 patients had > 105 colonies); and 4 patients required revision of one-third to two-thirds of the wound, and also presented extensive to confluent bacterial contamination.
In conclusion, aggressive surgical debridement and direct primary closure of superficial wound dehiscence after median sternotomy seems to be a safe and effective treatment. A positive culture of open wounds does not seem to contraindicate primary closure and may reduce the risk of spreading infection. When compared with secondary healing, the healing time, patients' discomfort, hospital costs, and hospital staff involvement are significantly reduced.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. Gorlitzer, F. Wagner, S. Pfeiffer, S. Folkmann, J. Meinhart, T. Fischlein, H. Reichenspurner, and M. Grabenwoger A prospective randomized multicenter trial shows improvement of sternum related complications in cardiac surgery with the Posthorax(R) support vest Interact CardioVasc Thorac Surg, May 1, 2010; 10(5): 714 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gorlitzer, S. Folkmann, J. Meinhart, P. Poslussny, M. Thalmann, G. Weiss, M. Bijak, and M. Grabenwoeger A newly designed thorax support vest prevents sternum instability after median sternotomy Eur J Cardiothorac Surg, August 1, 2009; 36(2): 335 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Khalafi, D. W. Bradford, and M. G. Wilson Topical application of autologous blood products during surgical closure following a coronary artery bypass graft Eur J Cardiothorac Surg, August 1, 2008; 34(2): 360 - 364. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zeitani, A. Penta de Peppo, A. Bianco, F. Nanni, A. Scafuri, F. Bertoldo, A. Salvati, S. Nardella, and L. Chiariello Performance of a Novel Sternal Synthesis Device After Median and Faulty Sternotomy: Mechanical Test and Early Clinical Experience Ann. Thorac. Surg., January 1, 2008; 85(1): 287 - 293. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zeitani, A. P. de Peppo, M. Moscarelli, L. G. Wolf, A. Scafuri, P. Nardi, F. Nanni, E. Di Marzio, P. De Vico, and L. Chiariello Influence of sternal size and inadvertent paramedian sternotomy on stability of the closure site: A clinical and mechanical study J. Thorac. Cardiovasc. Surg., July 1, 2006; 132(1): 38 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fleck, R. Moidl, P. Giovanoli, O. Aszmann, A. Bartunek, A. Blacky, M. Grabenwoger, and E. Wolner A conclusion from the first 125 patients treated with the vacuum assisted closure system for postoperative sternal wound infection Interact CardioVasc Thorac Surg, April 1, 2006; 5(2): 145 - 148. [Abstract] [Full Text] [PDF] |
||||
![]() |
Does use of a right internal thoracic artery increase deep wound infection and risk after previous use of a left internal thoracic artery? J. Thorac. Cardiovasc. Surg., March 1, 2006; 131(3): 609 - 613. |
||||
![]() |
J. Zeitani, A. P. de Peppo, R. De Paulis, P. Nardi, A. Scafuri, S. Nardella, and L. Chiariello Benefit of Partial Right-Bilateral Internal Thoracic Artery Harvesting in Patients at Risk of Sternal Wound Complications Ann. Thorac. Surg., January 1, 2006; 81(1): 139 - 143. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |